Searched for
ASCENT PHARMAHEALTH LTD
KKR to lend $100 million to Strides Arcolab's promoters“This would be a pure structured long-term credit facility, which KKR has been doing in India for some time now," said one of the sources m...- Strides Arcolab completes acquisition of Aspen's generic business in AustraliaThe acquisition included access to the product pipeline that was under development by Aspen and a number of major product launches slated f...
- Strides Arcolab surges as company to buy some Australia drug assets from South Africa's Aspen Pharmacare; ends 8% higherStrides Arcolab today said it will acquire South Africa's Aspen Pharmacare's portfolio of branded and generics products in Australia for ab...
- Strides Arcolab January-March net profit zooms to Rs 642 croreThe Bangalore-headquartered firm had sold its entire stake in Australian subsidiary Ascent Pharmahealth to Watson Pharmaceuticals.
- More M&A deals in Jan but for less value: Grant ThorntonThe total value of M&A transactions announced in January fell sharply by over 44 per cent year-on-year to USD 1.31 billion
- Strides Arcolab may fetch Rs 1250 cr from sale of domestic unitsStrides has received offers from a variety of global generic drug manufacturers as well as some Indian drug-makers and PE funds for the bus...
- Strides sells Australian unit to Watson Pharma for AUD 375 mnDrug firm Strides Arcolab today said it has sold its entire stake in Australian subsidiary Ascent Pharmahealth to Watson Pharmaceuticals fo...
- Strides Arcolab shares hit lifetime high on Ascent saleShares of drug firm Strides Arcolab skyrocketed by 20 per cent to hit a lifetime high on the bourses today after the company sold its entir...
- Strides Arcolab sold 94% stake in its subsidiary Ascent Pharma health to Watson PharmaceuticalsArcolab sold 94% stake in its subsidiary Ascent Pharmahealth to Watson Pharmaceuticals for an undisclosed amount.
- Strides to up stake in Australian pharma to 94%Strides Arcolab will be consolidating its stake in Australian firm Ascent Pharmahealth. Currently, it holds 60.3% in the firm and plans to ...
- Strides plans to raise $100 mnThe money would be primarily used for acquisitions, investments and other capital expenditure, the EGM notice to shareholders said.
- Strides Arcolab acquires majority stake in Australian firmPharmaceutical firm Strides Arcolab today said it has completed acquisition of 50.1 per cent stake in Australia stock exchange listed firm ...
Load More- Strides Arcolab January-March net profit zooms to Rs 642 crore
